Modafinil In Debilitating fatigue After Stroke (MIDAS): study protocol for a randomised, double-blinded, placebo-controlled, crossover trial

BACKGROUND: Fatigue is a common symptom in stroke survivors for which there is currently no proven therapy. Modafinil is a wakefulness-promoting agent with established benefits in other disease models. We aim to test if modafinil will improve patient’s self-reported fatigue scores when compared to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lillicrap, Thomas, Krishnamurthy, Venkatesh, Attia, John, Nilsson, Michael, Levi, Christopher R., Parsons, Mark W., Bivard, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989372/
https://www.ncbi.nlm.nih.gov/pubmed/27534856
http://dx.doi.org/10.1186/s13063-016-1537-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989372/
https://www.ncbi.nlm.nih.gov/pubmed/27534856
http://dx.doi.org/10.1186/s13063-016-1537-4

Ejemplares similares